Natural History Study of Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (ACAPPELLA)

A Natural History Study of Canavan Disease

NCT02851563 ·Status: COMPLETED

Transcriptome and Metabolic Analyses of CHAPLE Disease

NCT03950804 ·Status: UNKNOWN

Open-label Pilot Study of Abatacept for the Treatment of Vitiligo

NCT02281058 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

NCT04889430 ·Status: COMPLETED ·Phase: PHASE3

Kineret CAPS Post Authorisation Study

NCT02326376 ·Status: COMPLETED

Avacostar - (PASS)

NCT05897684 ·Status: RECRUITING

Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)

NCT01045772 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

NCT01302860 ·Status: COMPLETED ·Phase: PHASE3

An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context

NCT06720870 ·Status: RECRUITING

Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

NCT02004691 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

NCT00685373 ·Status: COMPLETED ·Phase: PHASE3

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

NCT02592798 ·Status: COMPLETED ·Phase: PHASE2

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

NCT04817618 ·Status: RECRUITING ·Phase: PHASE3

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

NCT06674577 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2

Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut

NCT07157189 ·Status: NOT_YET_RECRUITING

MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASE

NCT01780363 ·Status: COMPLETED

The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis

NCT03531996 ·Status: COMPLETED

Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid

NCT01559155 ·Status: TERMINATED

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis

NCT00468208 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis

NCT00059748 ·Status: RECRUITING

Characterization of the Fungal Origins in the Autoimmune Polyendocrinopathy of Type 1 Compared With the Autoimmune Polyendocrinopathies of Type 2

NCT03800056 ·Status: TERMINATED

Cortico-saving Treatments Proposed for CLIPPERS: a First Cohort

NCT01740180 ·Status: TERMINATED

Pharmacokinetics of Cyclosporin in Nephrotic Syndrome

NCT01616446 ·Status: COMPLETED

Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome

NCT01730495 ·Status: TERMINATED ·Phase: PHASE2

Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis

NCT00315497 ·Status: COMPLETED